[1] Dougherty T J, Gomer C J, Henderson B W, et al. Photodynamic therapy[J]. Journal of the National Cancer Institute, 1998, 90(12): 889-905.

[2] Allison R R, Mota H C, Bagnato V S, et al. Bio-nanotechnology and photodynamic therapy-state of the art review[J]. Photodiagnosis and Photodynamic Therapy, 2008, 5(1): 19-28.

[3] Lyons M, Phang I, Eljamel S. The effects of PDT in primary malignant brain tumours could be improved by intraoperative radiotherapy[J]. Photodiagnosis and Photodynamic Therapy, 2012, 9(1): 40-45.

[4] Paszko E, Ehrhardt C, Senge M O, et al. Nanodrug applications in photodynamic therapy[J]. Photodiagnosis and Photodynamic Therapy, 2011, 8(1): 14-29.

[5] Gary-Bobo M, Hocine O, Brevet D, et al. Cancer therapy improvement with mesoporous silica nanoparticles combining targeting, drug delivery and PDT[J]. International Journal of Pharmaceutics, 2012, 423(2): 509-515.

[6] Senge M O. mTHPC-A drug on its way from second to third generation photosensitizer?[J]. Photodiagnosis and Photodynamic Therapy, 2012, 9(2): 170-179.

[7] Shibu E S, Hamada M, Murase N, et al. Nanomaterials formulations for photothermal and photodynamic therapy of cancer[J]. Journal of Photochemistry and Photobiology C: Photochemistry Reviews, 2013, 15(1): 53-72.

[8] Huang K Q, Chen L, Xiong J W, et al. Preparation and characterization of visible-light-activated Fe-N Co-doped TiO2 and its photocatalytic inactivation effect on leukemia tumors[J]. International Journal of Photoenergy, 2012, 2012(14): 1910-1912.

[9] Akpan U G, Hameed B H. Parameters affecting the photocatalytic degradation of dyes using TiO2-based photocatalysts: a review[J]. Journal of Hazardous Materials, 2009, 170(2): 520-529.

[10] Medintz I L, Mattoussi H. Quantum dot-based resonance energy transfer and its growing application in biology[J]. Physical Chemistry Chemical Physics, 2009, 11(1): 17-45.

[11] Yaghini E, Seifalian A M, Macrobert A J. Quantum dots and their potential biomedical applications in photosensitization for photodynamic therapy[J]. Nanomedicine, 2009, 4(3): 353-363.

[12] Garcia A M F, Fernandes M S F, Coutinho P J G. CdSe/TiO2 core-shell nanoparticles produced in AOT reverse micelles: applications in pollutant photodegradation using visible light[J]. Nanoscale Research Letters, 2011, 6(1): 1-4.

[13] FengH, Thanhthuy TT, ChenL, et al. Visible light-induced efficiently oxidative decomposition of p-Nitrophenol by CdTe/TiO2 nanotube arrays[J]. Chemical Engineering Journal, 2013, 215-216: 591- 599.

[14] 张居正, 高善民, 宋佳, 等. CdSe/TiO2纳米复合材料的研究进展[J]. 微纳电子技术, 2011, 48(1): 26-36.

    Zhang J Z, Gao S M, Song J, et al. Research development on CdSe/TiO2 nanocomposites[J]. Micronanoelectronic Technology, 2011, 48(1): 26-36.

[15] 薛婷, 郭文博, 梁雪影, 等. 基于CdSe掺杂锐钛矿TiO2的可见光体外灭活HL60细胞实验研究[J]. 激光生物学报, 2017, 26(3): 224-231.

    Xue T, Guo W B, Liang X Y, et al. An experimental study on the visible light inactivated HL60 cells in vitro based on CdSe doped anatase TiO2[J]. Acta Laser Biology Sinica, 2017, 26(3): 224-231.

[16] Parker N, Turk M J, Westrick E, et al. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay[J]. Analytical Biochemistry, 2005, 338(2): 284-293.

[17] Hilgenbrink A R, Low P S. Folate receptor-mediated drug targeting from therapeutics to diagnostics[J]. Journal of Pharmaceutical Sciences, 2005, 94(10): 2135-2146.

[18] Ross J F, Wang H, Behm F G, et al. Folate receptor type β is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia[J]. Cancer, 1999, 85(2): 348-357.

[19] Pan X Q, Zheng X, Shi G, et al. Strategy for the treatment of acute myelogenous leukemia based on folate receptor β-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid[J]. Blood, 2002, 100(2): 594-602.

[20] 符秋伟, 梁雪影, 薛婷, 等. 基于叶酸修饰的S-TiO2的PDT体外灭活HL60细胞实验研究[J]. 激光生物学报, 2017, 26(1): 30-36.

    Fu Q W, Xue X Y, Xue T, et al. An experimental study on the photocatalytic inactivation of HL60 cells in vitro based on sulfur-doped titanium dioxide modified folic acid[J]. Acta Laser Biology Sinica, 2017, 26(1): 30-36.

[21] 李莉莉, 郑泽鳞, 黄康强, 等. 基于ALA-PDT的HL60细胞中的活性氧检测[J]. 光电子, 2011, 1(2): 11-15.

    Li L L, Zheng Z L, Huang K Q, et al. ROS detection in HL60 based on ALA-PDT[J]. Optoelectronics, 2011, 1(2): 11-15.

[22] 熊建文, 肖化, 张镇西. MTT法和CCK-8法检测细胞活性之测试条件比较[J]. 激光生物学报, 2007, 16(5): 559-562.

    Xiong J W, Xiao H, Zhang Z X. An experimental research on different detections between MTT and CCK-8[J]. Acta Laser Biology Sinica, 2007, 16(5): 559-562.

[23] Monshi A, Foroughi M R, Monshi M R. Modified Scherrer equation to estimate more accurately nano-crystallite size using XRD[J]. World Journal of Nano Science and Engineering, 2012, 2(2): 154-160.

[24] Harada Y, Ogawa K, Irie Y, et al. Ultrasound activation of TiO2 in melanoma tumors[J]. Journal of Controlled Release, 2011, 149(2): 190-195.

[25] Irena M, Jarmila K. Role of ER stress response in photodynamic therapy: ROS generated in different subcellular compartments trigger diverse cell death pathways[J]. Plos One, 2012, 7(3): e32972.

[26] Chen Y K, Senadi G C, Lee C H, et al. Apoptosis induced by 2-aryl benzothiazoles-mediated photodynamic therapy in melanomas via mitochondrial dysfunction[J]. Chemical Research in Toxicology, 2014, 27(7): 1187-1198.